EyePoint Pharmaceuticals Inc. EYPT
$12.53
▲ +4.24% 24H
About
EyePoint Pharmaceuticals Inc. is a specialty biopharmaceutical company focused on developing and commercializing innovative ophthalmic products. Its primary purpose is to treat serious eye disorders, particularly targeting diseases like wet age-related macular degeneration (AMD), diabetic macular edema, and retinal vei…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees165
TickerEYPT
Statistics
Market Cap$1.05B
Revenue (TTM)$31.4M
Net Income-$232.0M
Net Margin-739.4%
EPS$-3.17
P/E-3.94
P/S135.77
P/B31.14
EV/EBITDA-4.09
ROE-102.7%
Dividend Yield—
Price$12.53
Data: Twelve Data · Revenue = mcap / P/S